Schrödinger, Inc. (NASDAQ:SDGR) Shares Acquired by Nikko Asset Management Americas Inc.

Nikko Asset Management Americas Inc. lifted its holdings in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 108.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,464,911 shares of the company’s stock after buying an additional 1,283,949 shares during the period. Nikko Asset Management Americas Inc.’s holdings in Schrödinger were worth $47,499,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Monaco Asset Management SAM acquired a new position in shares of Schrödinger during the 4th quarter worth approximately $1,543,000. Swiss National Bank increased its position in shares of Schrödinger by 1.2% during the fourth quarter. Swiss National Bank now owns 125,100 shares of the company’s stock worth $2,413,000 after purchasing an additional 1,500 shares in the last quarter. Amundi increased its position in shares of Schrödinger by 197.7% during the fourth quarter. Amundi now owns 26,753 shares of the company’s stock worth $544,000 after purchasing an additional 17,766 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Schrödinger during the fourth quarter worth approximately $325,000. Finally, Proficio Capital Partners LLC purchased a new stake in shares of Schrödinger during the fourth quarter worth approximately $218,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Schrödinger

In other news, CFO Geoffrey Craig Porges sold 5,491 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the completion of the transaction, the chief financial officer now directly owns 27,544 shares in the company, valued at approximately $599,357.44. This represents a 16.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 8.60% of the company’s stock.

Schrödinger Stock Up 4.4 %

Shares of NASDAQ:SDGR opened at $22.90 on Monday. The business has a fifty day moving average of $22.69 and a two-hundred day moving average of $20.70. The stock has a market cap of $1.67 billion, a P/E ratio of -9.79 and a beta of 1.62. Schrödinger, Inc. has a 52-week low of $16.67 and a 52-week high of $29.15.

Schrödinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.20). The business had revenue of $88.32 million for the quarter, compared to analysts’ expectations of $83.20 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. On average, equities analysts anticipate that Schrödinger, Inc. will post -2.37 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on SDGR. KeyCorp boosted their price target on Schrödinger from $25.00 to $27.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Piper Sandler dropped their price target on Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Schrödinger presently has an average rating of “Buy” and an average target price of $32.29.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.